These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36446995)

  • 1. A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis.
    Bawa Z; Saini B; McCartney D; Bedoya-Pérez M; McLachlan AJ; McGregor IS
    Int J Clin Pharm; 2023 Apr; 45(2):375-386. PubMed ID: 36446995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge, experiences, and attitudes of Australian General Practitioners towards medicinal cannabis: a 2021-2022 survey.
    Bawa Z; McCartney D; Manocha R; McGregor IS
    BMC Prim Care; 2022 Dec; 23(1):330. PubMed ID: 36529730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community pharmacists' lack of knowledge and confidence in non-prescription cannabidiol products.
    Patel S; Doroudgar S; Ip EJ
    Res Social Adm Pharm; 2021 Jul; 17(7):1356-1360. PubMed ID: 33041209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey.
    Karanges EA; Suraev A; Elias N; Manocha R; McGregor IS
    BMJ Open; 2018 Jul; 8(7):e022101. PubMed ID: 29970456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National survey identifying community pharmacist preceptors' experience, knowledge, attitudes, and behaviors influencing intent to recommend cannabidiol products.
    Nichols MA; Arnett SJ; Fa B; Marchionda RA; Cutting MC; McDonald MR; Miller ML
    J Am Pharm Assoc (2003); 2021; 61(4S):S91-S104. PubMed ID: 33558186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists.
    Szaflarski M; McGoldrick P; Currens L; Blodgett D; Land H; Szaflarski JP; Segal E
    Epilepsy Behav; 2020 Aug; 109():107102. PubMed ID: 32442891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community pharmacists' attitudes and opinions towards supplying clozapine.
    Gan YL; O'Reilly CL
    Int J Clin Pharm; 2018 Oct; 40(5):1116-1130. PubMed ID: 29936642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of Wisconsin pharmacists about cannabinoid products: Are we ready to recommend?
    Emmerling S; Martin B; Schmitz N
    J Am Pharm Assoc (2003); 2021; 61(6):e71-e75. PubMed ID: 34456146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of Pharmacists' Knowledge of Connecticut's Medical Cannabis Program.
    Reece SM; Holle L; Mukherjee K
    Cannabis Cannabinoid Res; 2021; 6(1):66-73. PubMed ID: 33614954
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacists' use of guidelines for the supply of non-prescription medicines: a cross-sectional survey.
    Mill D; Johnson JL; Percival M; Lee K; Salter SM; D'Lima D; Seubert L; Clifford R; Page AT
    Int J Pharm Pract; 2023 Sep; 31(5):478-488. PubMed ID: 37440321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-the-counter orlistat: early experiences, views and attitudes of community pharmacists in Great Britain.
    Weidmann AE; Cunningham S; Gray G; Hansford D; McLay J; Broom J; Stewart D
    Int J Clin Pharm; 2011 Aug; 33(4):627-33. PubMed ID: 21573977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the preparedness and future-readiness of Malaysian community pharmacists in Klang Valley regarding the use of medical marijuana.
    Kuang FW; Farrukh MJ
    BMC Health Serv Res; 2024 Apr; 24(1):524. PubMed ID: 38664704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' Perspectives.
    Isaac S; Saini B; Chaar BB
    PLoS One; 2016; 11(5):e0155113. PubMed ID: 27171490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community pharmacists' views, attitudes and early experiences of over-the-counter simvastatin.
    Hansford D; Cunningham S; John D; McCaig D; Stewart D
    Pharm World Sci; 2007 Aug; 29(4):380-5. PubMed ID: 17357811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicinal cannabis in Latin America: History, current state of regulation, and the role of the pharmacist in a new clinical experience with cannabidiol oil.
    Cáceres Guido P; Riva N; Calle G; Dell'Orso M; Gatto M; Sberna N; Schaiquevich P
    J Am Pharm Assoc (2003); 2020; 60(1):212-215. PubMed ID: 31706799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge, attitude, and practice of pharmacy professionals on generic medicines in Eastern Ethiopia: A cross-sectional study.
    Mohammed AS; Woldekidan NA; Mohammed FA
    PLoS One; 2020; 15(7):e0235205. PubMed ID: 32658918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge and practices of community pharmacists towards non-prescription dispensing of antibiotics in Northern Nigeria.
    Abubakar U; Tangiisuran B
    Int J Clin Pharm; 2020 Apr; 42(2):756-764. PubMed ID: 32270378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-prescription medicines: current issues in Australian community pharmacy.
    Tan AC; Emmerton L
    Int J Pharm Pract; 2009 Aug; 17(4):207-13. PubMed ID: 20217945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.